Flow‐assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow‐up of wasp venom immunotherapy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Correct identification of the culprit venom is a prerequisite for specific venom immunotherapy (VIT). Despite the efficacy of VIT, issues as how to monitor treatment and when to discontinue maintenance therapy remain to be established. Methods: To evaluate diagnostic performances of the basophil activation test (BAT) in wasp venom allergy, 80 patients with a definite history of wasp venom anaphylaxis (systemic reactors) and 14 wasp‐stung asymptomatic controls (stung controls) were enrolled. Venom‐induced basophil activation was analyzed flow cytometrically by double‐labeling with anti‐IgE and anti‐CD63. Results were compared to wasp IgE levels and results of a venom skin test (VST). To establish whether the BAT constitutes a candidate marker to monitor VIT, the BAT was repeated in 22 patients on the 5th day of a build‐up course and after 6 months of maintenance VIT. Whether the BAT could contribute in the decision of discontinuing VIT was assessed in a cross‐sectional analysis in 30 patients receiving treatment for 3 years. Results: Comparison between systemic reactors and stung controls revealed a sensitivity of 86.4% and specificity of 100% for venom IgE, and sensitivity of 81.8% for VST, respectively. In contrast to stung controls, patients demonstrated dose‐dependent venom‐induced basophil activation. The BAT attained a sensitivity of 83.8% and specificity of 100%. At the end of the build‐up course, no effect of VIT on the BAT was demonstrable. When the BAT was repeated after 6 months of treatment, submaximal stimulation of the cells demonstrated a significant decreased CD63 expression (P < 0.04). Patients having VIT for 3 years also demonstrated significantly lower venom‐induced CD63 expression (P < 0.001). After 3 years, 60% of the patients had a negative BAT for submaximal stimulation of the cells whereas only 17.9% of the patients had negativation of wasp IgE. Conclusions: The BAT is a reliable instrument for the diagnosis of wasp venom anaphylaxis and might constitute an instrument to monitor wasp VIT. © 2006 International Society for Analytical Cytology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greiner, M., Pfeiffer, D., & Smith, R. D. (2000) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(00)00115-x · Cited by 1,923
Bühring, H.-J., Streble, A., & Valent, P. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000077351 · Cited by 231
Cited by
Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy
Schmid, J. M., Würtzen, P. A., Dahl, R., & Hoffmann, H. J. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.029 · Cited by 63
Pros and Cons of Clinical Basophil Testing (BAT)
Hoffmann, H. J., Knol, E. F., Ferrer, M., Mayorga, L., Sabato, V., Santos, A. F., Eberlein, B., Nopp, A., & MacGlashan, D. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0633-6 · Cited by 50
Basophil Activation as Marker of Clinically Relevant Allergy and Therapy Outcome
Eberlein, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01815 · Cited by 47
Inuo, C., Kondo, Y., Tanaka, K., Nakajima, Y., Nomura, T., Ando, H., Suzuki, S., Tsuge, I., Yoshikawa, T., & Urisu, A. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000437325 · Cited by 31
Metadata
- Authors
- Ebo, D. G., Hagendorens, M. M., Schuerwegh, A. J., Beirens, L. M. ‐., Bridts, C. H., De Clerck, L. S., & Stevens, W. J.
- Venue
- Cytometry Part B: Clinical Cytometry
- Publisher
- Wiley
- Published
- 2006-11-16
- Volume
- 72B
- Issue
- 3
- Pages
- 196-203
- ISSN
- 1552-4949 (ISSN-L)
- 1552-4957
- OpenAlex
- W1978972165
- Cited by
- 89
- References
- 2
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.